Vaccines


  • HHS Advances Development of Ebola Vaccine
    The development of a vaccine to prevent Ebola virus disease will be accelerated with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). Under a one-year contract with Profectus ...More
    4 days ago Posted in News
  • New Perspectives for Development of an RSV Vaccine
    Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus ...More
    2 weeks ago Posted in News
  • Defective Gene Renders Rotavirus Vaccine Ineffective
    Every year rotavirus causes half a million diarrhea-related deaths amongst children in developing countries. Existing vaccines provide poor protection. The reason could be a widespread genetic resistance amongst children, according to virologists at Linköping ...More
    2 weeks ago Posted in News
  • By Studying Genome of Tickborne Pathogen, Researcher Aims to Develop Vaccines
    A Kansas State University professor is researching ways to keep animals and humans safe from tickborne diseases. Roman Ganta, professor of diagnostic medicine and pathobiology, has received a four-year $1.8 million National Institutes of Health grant to continue studying ...More
    2 weeks ago Posted in News
  • Pneumococcal Vaccine Reduces Antibiotic-Resistant Infections in Children by 62 Percent
    The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014. Pneumococcal infection – which can cause ...More
    2 weeks ago Posted in News
  • University of Maryland School of Medicine Begins Ebola Vaccine Trials in Mali
    Professor Myron M. Levine, MD, director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, the Center ...More
    3 weeks ago Posted in News
  • New Vaccines Targeting Adults and Teens are Best Chance to Eliminate TB by 2050
    Targets to eliminate tuberculosis (TB) by 2050 are more likely to be met if new vaccines are developed for adults and adolescents instead of for infants, according to new research published in the journal Proceedings of the National Academy of Sciences. Researchers at the ...More
    3 weeks ago Posted in News
  • WHO Reports on Experimental Ebola Vaccines
    The World Health Organization (WHO) organized an expert consultation Sept. 29-30, 2014 to assess the status of work to test and eventually license two candidate Ebola vaccines. More than 70 experts, including many from affected and neighboring countries in West Africa, ...More
    4 weeks ago Posted in News
  • NIH Awards Seven New Vaccine Adjuvant Discovery Contracts
    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability. ...More
    4 weeks ago Posted in News
  • NIH and FDA Win Top Award for Intellectual Property Licensing of Meningitis Vaccine
    The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) will receive a top national award for the year’s most outstanding intellectual property licensing deal, for technology transfer of a pioneering, low-cost meningitis vaccine launched in ...More
    5 weeks ago Posted in News
« Previous12345678910119293Next »